216 related articles for article (PubMed ID: 32972825)
1. A historical review of the role of cytokines involved in leishmaniasis.
Mirzaei A; Maleki M; Masoumi E; Maspi N
Cytokine; 2021 Sep; 145():155297. PubMed ID: 32972825
[TBL] [Abstract][Full Text] [Related]
2. Chemokines in host-parasite interactions in leishmaniasis.
Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in the immunity and immunopathogenesis in leishmaniases.
Saha B; Silvestre R
Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
[TBL] [Abstract][Full Text] [Related]
4. Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica.
Chanyalew M; Abebe M; Endale B; Girma S; Tasew G; van Zandbergen G; Ritter U; Gadisa E; Aseffa A; Laskay T
Cytokine; 2021 Sep; 145():155289. PubMed ID: 32951968
[TBL] [Abstract][Full Text] [Related]
5. How to master the host immune system? Leishmania parasites have the solutions!
Rossi M; Fasel N
Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
[TBL] [Abstract][Full Text] [Related]
6. [Immunopathology of American tegumentary leishmaniasis].
Castés M; Tapia FJ
Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
[TBL] [Abstract][Full Text] [Related]
7. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.
Soong L; Henard CA; Melby PC
Semin Immunopathol; 2012 Nov; 34(6):735-51. PubMed ID: 23053396
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Leishmania with the host macrophage.
Handman E; Bullen DV
Trends Parasitol; 2002 Aug; 18(8):332-4. PubMed ID: 12377273
[TBL] [Abstract][Full Text] [Related]
9. The role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil.
Espir TT; Figueira Lde P; Naiff Mde F; da Costa AG; Ramalho-Ortigão M; Malheiro A; Franco AM
J Immunol Res; 2014; 2014():481750. PubMed ID: 25295285
[TBL] [Abstract][Full Text] [Related]
10. The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection.
Chan A; Ayala JM; Alvarez F; Piccirillo C; Dong G; Langlais D; Olivier M
PLoS One; 2021; 16(12):e0262158. PubMed ID: 34972189
[TBL] [Abstract][Full Text] [Related]
11. [Leishmaniasis: principles of the immune response and function of nitric oxide].
Bogdan C
Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):409-14. PubMed ID: 9880934
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.
Reis LC; Ramos-Sanchez EM; Araujo FN; Leal AF; Ozaki CY; Sevillano OR; Uscata BA; Goto H
J Immunol Res; 2021; 2021():6614475. PubMed ID: 34036108
[TBL] [Abstract][Full Text] [Related]
13. Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization.
Azeredo-Coutinho RB; Matos DC; Armôa GG; Maia RM; Schubach A; Mayrink W; Mendonça SC
Clin Exp Immunol; 2008 Sep; 153(3):369-75. PubMed ID: 18627399
[TBL] [Abstract][Full Text] [Related]
14. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.
Okwor I; Uzonna JE
Immunotherapy; 2009 Sep; 1(5):765-76. PubMed ID: 20636022
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Manifestations of Human and Murine Leishmaniasis.
Scorza BM; Carvalho EM; Wilson ME
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629171
[TBL] [Abstract][Full Text] [Related]
17. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
[TBL] [Abstract][Full Text] [Related]
18. Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.
Pacheco-Fernandez T; Volpedo G; Verma C; Satoskar AR
Biochem Soc Trans; 2021 Feb; 49(1):297-311. PubMed ID: 33449103
[TBL] [Abstract][Full Text] [Related]
19. Animal models for the analysis of immune responses to leishmaniasis.
Sacks DL; Melby PC
Curr Protoc Immunol; 2015 Feb; 108():19.2.1-19.2.24. PubMed ID: 25640990
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
Passelli K; Billion O; Tacchini-Cottier F
Front Immunol; 2021; 12():649348. PubMed ID: 33732265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
